Biotechnology News

September 20, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (OMX: MVIR), announced today that simeprevir (TMC435) and TMC647055, a non-nucleoside inhibitor (NNI) will enter a phase IIa interferon free combination trial. Simeprevir is a once...

September 19, 2012

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The fifth annual BioPharm America™ conference kicked off in Boston, MA, today with the announcement of TransCelerate BioPharma, a new non-profit organization focused on accelerating...

September 19, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics files its quarterly financial results and provides an update on its core business.

September 19, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall announced it will be opening a state-of the-art Life Sciences Center of Excellence in Westborough, Massachusetts for life sciences customers in the northeast region of the U.S.

September 19, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that detailed results from its two pivotal clinical trials evaluating oral BG-12 (dimethyl fumarate) for the treatment of multiple sclerosis (MS) were published in the...

September 19, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (the “Company”) today announced that it has priced an underwritten public offering of $75.0 million in aggregate principal amount of its 7.00% senior...

September 19, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced the pricing of new term loans to be used in the refinancing of its existing senior secured bank debt. Syndication has completed for the new senior secured bank debt, comprising...

September 19, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced its support of the first national Myelofibrosis Awareness Day, which will be held on Sept. 20, 2012. The inaugural recognition day is being led by the MPN...

September 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) previously announced that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL, from 8:00 a.m. until approximately 3...

September 19, 2012

BOSTON & WASHINGTON & CARLSBAD, Calif.--(BUSINESS WIRE)--This year’s announcement of the best and brightest emerging biotech companies took place at BioPharm America™ in Boston today. The Fierce 15 is a much anticipated who’s who list of...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seaside Therapeutics published two papers in Science Translational Medicine, supporting disease-modifying potential for drug, STX209 (arbaclofen), for the treatment of fragile X syndrome (FXS)

September 19, 2012

SEATTLE--(BUSINESS WIRE)--Scientists at the Allen Institute for Brain Science reported in the latest issue of the journal Nature that human brains share a consistent genetic blueprint and possess enormous biochemical complexity. The findings stem...

September 19, 2012

COLUMBUS, Ohio--(BUSINESS WIRE)--Today throughout Ohio, at least 1,280 bioscience-related organizations are either manufacturing products, providing essential services, or researching the next breakthrough. Ranging from the large and well known—...

September 19, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

September 19, 2012

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--CRI Lifetree has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as Chief Operating Officer and Jose Marcos as East Coast Director of Clinical Operations.

September 19, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, has announced a new syndicated report series entitled LaunchTrends: Aubagio. Aubagio (...

September 19, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics Corp. and DuPont Nutrition & Health (NYSE: DD) today announced a collaboration aimed at commercializing AvidBiotics’ Purocin™ antibacterial proteins to significantly improve food...

September 19, 2012

BONN, Germany--(BUSINESS WIRE)--Cardionovum: clinical trials confirm “excellent device performance with high procedural success and absence of clinical events out to six months follow-up”

September 19, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company’s new drug application (NDA) for pomalidomide at...

September 19, 2012

CHAPEL HILL, N.C.--(BUSINESS WIRE)--G1 Therapeutics announces partnership with Hatteras Venture Partners and expansion of management team.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akrivis Technologies has reached a strategic agreement with USBiological to co-develop novel Research-Use-Only products based on its Z-TECT platform for the ultrasensitive detection of biomarkers.

September 19, 2012

WASHINGTON--(BUSINESS WIRE)--As part of its commitment to advancing research in the field of otolaryngology/head and neck surgery (OHNS), Cook Medical with a strong history of philanthropy to encourage and support research and education, has...

September 19, 2012

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics has initiated a Phase 1b/2a trial of its Tie2 activator, AKB-9778, for the treatment of diabetic macular edema (DME). Safety and Efficacy data are expected in 2013.

September 19, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Colby Pharmaceuticals Acquires Othera Pharmaceuticals

September 19, 2012

CHICAGO--(BUSINESS WIRE)--Research and development (R&D) expenditures in the biotechnology industry grew five percent in 2011, bouncing back after a decline the prior year, according to a new study from BDO USA, LLP.

September 19, 2012

MONTREAL--(BUSINESS WIRE)--Angiochem named by FierceBiotech one of 2012’s Fierce 15, designating it as one of the most promising private biotechnology companies in the industry

September 19, 2012

BOSTON--(BUSINESS WIRE)--SpringLeaf Therapeutics hires Pieter Muntendam, MD, as its President and CEO to advanced the Company's breakthrough technology that transforms the administration of non-orally administered medication.

September 19, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its Molecular Biology Center of Excellence in Vilnius, Lithuania.

September 19, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) announced that Chief Executive Officer Michael D. West, Ph.D. will present at the Stem Cells USA & Regenerative Medicine Congress 2012 in Cambridge, MA on Thursday, September 20...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide Inc., a medical device company specializing in precision surgical energy instruments, recently announced the launch of a next-generation product designed for laparoscopic endometriosis procedures. The...

September 19, 2012

DEERFIELD, Ill. & NEWTOWN, Pa.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) and Onconova Therapeutics, Inc. today announced that they have entered into a European licensing agreement for rigosertib, a novel targeted anti-cancer...

September 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The most important factor for drug companies when partnering with a companion diagnostics (CDx) developer is its technological capabilities, according to a recent study by Cutting Edge Information....

September 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug companies eager to work with end-users find patient communication to be the leading external difficulty for marketing teams, according to a recent study by Cutting Edge Information.

September 19, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen named to FierceBiotech's 2012 Fierce 15. Honor reflects company's commitment to develop innovative microRNA (miRNA)-based therapeutics to address disease areas of high unmet medical need.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seaside Therapeutics Inc. announced that FierceBiotech has selected the Company as one of the 2012 Fierce 15, designating it as one of the most promising private companies in the biotech industry.

September 19, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Receives Initial $2.9 million from Warrant Exchange Offer

September 19, 2012

SEATTLE--(BUSINESS WIRE)--Cadence Biomedical, a developer of medical devices that help people with severe disabilities walk, today announced the launch and commercial availability of its first product, the Kickstart™ Kinetic Orthosis. Kickstart...

September 19, 2012

LOS ANGELES--(BUSINESS WIRE)--Fidelis Diagnostics, Inc. Expands Operations to Colorado; Sabrina Bayles Tapped as Manager for New Denver Office

September 19, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of Illumina, is a leading provider of solutions...

September 19, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem propels its Independent Data Monitoring Committee, Data Safety Monitoring Board and Clinical Endpoint/Event Committee services with oversight by adding Dr. Lisa Moore.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FierceBiotech Names Foundation Medicine as One of 2012’s Fierce 15

September 19, 2012

TORONTO--(BUSINESS WIRE)--he growing population suffering from obesity, diabetes and hypertension will lead to increased incidence of both acute and chronic wounds, and thus favor adoption of wound care biomaterials in the US.

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FierceBiotech today named bluebird bio as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth annual Fierce 15...

September 19, 2012

BASEL, Switzerland--(BUSINESS WIRE)--FierceBiotech today named Okairos as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry

September 19, 2012

SHARSHERET, Israel--(BUSINESS WIRE)--Morflora (www.morflora.com), focused on innovative non-transgenic trait delivery technology for plant protection reports today that its TraitUP™...

September 19, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals initiates Phase 3 study of ZEVALIN in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

September 19, 2012

JERUSALEM--(BUSINESS WIRE)--Gamida Cell, a leader in adult stem cell expansion technologies and products, announced today that it has completed enrollment for a Phase I/II clinical trial of NiCord, the company’s second pipeline product. NiCord is...